Author of the publication

Fluor-18-Misonidazol-PET/CT unter kurativ intendierter Radiochemotherapie bei Patienten mit lokal fortgeschrittenen Kopf-Hals-Tumoren (KHT)--eine prospektive Explorationsstudie

, , , , , , , , , and . Nuklearmedizin, (2013)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Kotzerke, Jörg
add a person with the name Kotzerke, Jörg
 

Other publications of authors with the same name

FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy, , , , , , , , , and 1 other author(s). Radiotherapy and Oncology, 122 (3): 437--444 (2017)Usefulness of voxel-wise Pearson correlation coefficient for reproducibility and repeatability measurements in PET, , , , , and . Nuklearmedizin, (2012)Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure, , , , , , , , , and 1 other author(s). Acta Oncologica, 54 (9): 1355--1363 (2015)Stabilität des Hypoxietracers 18 F-FMISO während sequentieller PET-Untersuchungen bei Patienten mit radiochemotherapierten HNO-Tumoren und Korrelation von funktionellen Tumor-Subvolumina zur Rezidivlokalisation, , , , , , , , , and . Strahlentherapie und Onkologie, (2014)Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer, , , , , , , , , and . Radiotherapy and Oncology, 105 (1): 21--28 (2012)Zwei oder vier Stunden 18F FMISO-PET in Kopf-Hals-Karzinomen: Wann ist der Bildkontrast am höchsten?, , , , , , , and . Nuklearmedizin, (2011)Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients, , , , , , , , , and 1 other author(s). Clinical and translational radiation oncology, (2019)Fluor-18-Misonidazol-PET/CT unter kurativ intendierter Radiochemotherapie bei Patienten mit lokal fortgeschrittenen Kopf-Hals-Tumoren (KHT)--eine prospektive Explorationsstudie, , , , , , , , , and . Nuklearmedizin, (2013)